Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Virol J ; 20(1): 57, 2023 03 30.
Article in English | MEDLINE | ID: covidwho-2275191

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the performance of ten (10) SARS-CoV-2 serological rapid diagnostic tests in comparison with the WANTAI SARS-CoV-2 Ab ELISA test in a laboratory setting. MATERIALS AND METHODS: Ten (10) SARS-CoV-2 serological rapid diagnostic tests (RDTs) for SARS-CoV-2 IgG/IgM were evaluated with two (2) groups of plasma tested positive for one and negative for the other with the WANTAI SARS-CoV-2 Ab ELISA. The diagnostic performance of the SARS-CoV-2 serological RDTs and their agreement with the reference test were calculated with their 95% confidence intervals. RESULTS: The sensitivity of serological RDTs ranged from 27.39 to 61.67% and the specificity from 93.33 to 100% compared to WANTAI SARS-CoV-2 Ab ELISA test. Of all the tests, two tests (STANDARD Q COVID-19 IgM/IgG Combo SD BIOSENSOR and COVID-19 IgG/IgM Rapid Test (Zhejiang Orient Gene Biotech Co., Ltd)) had a sensitivity greater than 50%. In addition, all ten tests had specificity greater than or equal to 93.33% each. The concordance between RDTs and WANTAI SARS-CoV-2 Ab ELISA test ranged from 0.25 to 0.61. CONCLUSION: The SARS-CoV-2 serological RDTs evaluated show low and variable sensitivities compared to the WANTAI SARS-CoV-2 Ab ELISA test, with however a good specificity. These finding may have implications for the interpretation and comparison of COVID-19 seroprevalence studies depending on the type of test used.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , COVID-19/diagnosis , Burkina Faso , Seroepidemiologic Studies , Sensitivity and Specificity , Enzyme-Linked Immunosorbent Assay , Antibodies, Viral , Serologic Tests , Immunoglobulin M/analysis , Immunoglobulin G , COVID-19 Testing
2.
Int J Infect Dis ; 103: 525-526, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-1065178

ABSTRACT

During epidemic periods, HCW are vulnerable. In Africa, cohort studies implemented by the Institut Pasteur International Network in five countries showed after 3-month follow-up around 40% of the HCW have been infected by the SARS-CoV-2. So advocacy for HCW protection strategy need to be fostered and sustained by the health authorities all over the African continent.


Subject(s)
COVID-19/prevention & control , Health Personnel , SARS-CoV-2 , Africa/epidemiology , Cohort Studies , Epidemics , Humans , Personal Protective Equipment
SELECTION OF CITATIONS
SEARCH DETAIL